[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69632206D1 - (2-piperidin-1-yl-4-substituierte)-4-amino-2-chinazolin-derivate mit antihypertensiver wirkung, verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch - Google Patents

(2-piperidin-1-yl-4-substituierte)-4-amino-2-chinazolin-derivate mit antihypertensiver wirkung, verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch

Info

Publication number
DE69632206D1
DE69632206D1 DE69632206T DE69632206T DE69632206D1 DE 69632206 D1 DE69632206 D1 DE 69632206D1 DE 69632206 T DE69632206 T DE 69632206T DE 69632206 T DE69632206 T DE 69632206T DE 69632206 D1 DE69632206 D1 DE 69632206D1
Authority
DE
Germany
Prior art keywords
group
substituted
pct
methoxy
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69632206T
Other languages
English (en)
Other versions
DE69632206T2 (de
Inventor
Francesco Makovec
Walter Peris
Claudio Rovati
Angelo Rovati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm SpA
Original Assignee
Rotta Research Laboratorium SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Laboratorium SpA filed Critical Rotta Research Laboratorium SpA
Publication of DE69632206D1 publication Critical patent/DE69632206D1/de
Application granted granted Critical
Publication of DE69632206T2 publication Critical patent/DE69632206T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69632206T 1996-04-10 1996-07-31 (2-piperidin-1-yl-4-substituierte)-4-amino-2-chinazolin-derivate mit antihypertensiver wirkung, verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch Expired - Fee Related DE69632206T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT96TO000275A IT1286302B1 (it) 1996-04-10 1996-04-10 Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso
ITTO960275 1996-04-10
PCT/EP1996/003370 WO1997037979A1 (en) 1996-04-10 1996-07-31 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use

Publications (2)

Publication Number Publication Date
DE69632206D1 true DE69632206D1 (de) 2004-05-19
DE69632206T2 DE69632206T2 (de) 2005-04-28

Family

ID=11414541

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69632206T Expired - Fee Related DE69632206T2 (de) 1996-04-10 1996-07-31 (2-piperidin-1-yl-4-substituierte)-4-amino-2-chinazolin-derivate mit antihypertensiver wirkung, verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch

Country Status (11)

Country Link
US (1) US5985885A (de)
EP (1) EP0892790B1 (de)
JP (1) JP3987113B2 (de)
AT (1) ATE264312T1 (de)
AU (1) AU6788596A (de)
CA (1) CA2251308A1 (de)
DE (1) DE69632206T2 (de)
ES (1) ES2216057T3 (de)
IT (1) IT1286302B1 (de)
PT (1) PT892790E (de)
WO (1) WO1997037979A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3030561T3 (pl) 2013-08-07 2017-08-31 Cadila Healthcare Limited N-cyjanometyloamidy jako inhibitory kinaz janusowych
US9682955B2 (en) * 2014-09-09 2017-06-20 Janssen Pharmaceutica Nv Quinazoline derivatives useful as CB-1 inverse agonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
GB1383409A (en) * 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US4351832A (en) * 1980-04-18 1982-09-28 American Home Products Corporation 2-(Piperazinyl)-4-pyrimidinamines
FI70411C (fi) * 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
DE3336409A1 (de) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg Chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CA1307786C (en) * 1984-12-14 1992-09-22 Keiichi Yokoyama Quinazoline derivatives and antihypertensive preparations containing same as effective components
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
IT1270993B (it) * 1994-03-18 1997-05-26 Recordati Chem Pharm Derivati chinzolilamminici attivi come alfa-antagonisti

Also Published As

Publication number Publication date
DE69632206T2 (de) 2005-04-28
ITTO960275A0 (de) 1996-04-10
WO1997037979A1 (en) 1997-10-16
CA2251308A1 (en) 1997-10-16
US5985885A (en) 1999-11-16
EP0892790A1 (de) 1999-01-27
JP2000508297A (ja) 2000-07-04
JP3987113B2 (ja) 2007-10-03
ATE264312T1 (de) 2004-04-15
EP0892790B1 (de) 2004-04-14
PT892790E (pt) 2004-06-30
AU6788596A (en) 1997-10-29
ES2216057T3 (es) 2004-10-16
ITTO960275A1 (it) 1997-10-10
IT1286302B1 (it) 1998-07-08

Similar Documents

Publication Publication Date Title
Rao et al. MMP‐1 and MMP‐9 regulate epidermal growth factor‐dependent collagen loss in human carotid plaque smooth muscle cells
ATE538090T1 (de) Verfahren zur herstellung von 2-iminopyrrolidin- derivaten
NO20021229L (no) Benzamider og relaterte inhibitorer for faktor Xa
NO984084L (no) 4-Amino-pyrimidin-derivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte ved fremstilling derav
WO2000071511A3 (en) INHIBITORS OF FACTOR Xa
DE69831876D1 (de) (4)-[aryl(piperidin-4-yl) aminobenzamidderivate die an delta-opioid rezeptor binden
NO933248L (no) Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE50106698D1 (de) Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
TR200201168T2 (tr) CGRP-Antagonistleri-yeni siklopropanlar içeren ilaçlar ve üretim yöntemleri.
ATE264107T1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
DK0808303T3 (da) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreceptorantagonister
DE69632206D1 (de) (2-piperidin-1-yl-4-substituierte)-4-amino-2-chinazolin-derivate mit antihypertensiver wirkung, verfahren zu ihrer herstellung und ihrem pharmazeutischen gebrauch
TR200002839T2 (tr) 5-Hidroksibenzo[b]tiofen-3-karboksilik asit türevlerinin hazırlanması.
FR2738569B1 (fr) Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique
NO974945D0 (no) Substituerte fenylamidiner, legemidler som inneholder disse forbindelser, samt fremgangsmåte for fremstilling av disse
DK1246790T3 (da) Substituerede 1- og 2-naphthol-Mannichbaser
ATE237621T1 (de) Herstellung von einem kristallinen amoxicillinsalz
ATE227714T1 (de) ((2-substituierte-5-(3-thienyl)-benzyl)-(2-((2- isopropoxy-5-fluoro)-phenoxy)-ethyl)-amine, verfahren zu ihrer herstellung und ihre verwendung als medikamente
ATE278667T1 (de) Tetramsäure-derivate zur verwendung in medizin und lebensmitteltechnologie
SE0000532L (sv) Ny användning

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ROTTAPHARM S.P.A., MILANO, IT

8339 Ceased/non-payment of the annual fee